Learn More
Tocris Bioscience™ PF CBP1
Selective CBP/p300 bromodomain inhibitor
Supplier: Tocris Bioscience™ 5801/50
Description
Selective CBP/p300 bromodomain inhibitor (IC50 values are 125 and 363 nM, respectively). Exhibits >100-fold selectivity for CBP over BRD4. Also exhibits selectivity over a panel of other bromodomains. Reduces LPS-induced IL-1β, IL-6 and IFN-β expression in macrophages in vitro. Also downregulates RGS4 expression in primary cortical neurons in vitro.Negative Control also available.
Specifications
5-(Dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole | |
50 mg | |
C29H36N4O3 | |
>98% |
1962928-21-7 | |
Bromodomain Inhibitors | |
488.62 |
Safety and Handling
Recommended Storage : Store at 4°C
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.